Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed
Open Access
- 30 April 2011
- journal article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 6 (4), 774-780
- https://doi.org/10.1097/jto.0b013e31820cf053
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor TreatmentClinical Cancer Research, 2010
- KRAS Mutation: Comparison of Testing Methods and Tissue Sampling Techniques in Colon CancerThe Journal of Molecular Diagnostics, 2010
- Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutationCancer and Metastasis Reviews, 2010
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALKJournal of Clinical Oncology, 2009
- Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell MalignanciesJournal of Clinical Oncology, 2009
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaThe New England Journal of Medicine, 2009
- Therapeutics by Cytotoxic Metabolite Accumulation: Pemetrexed Causes ZMP Accumulation, AMPK Activation, and Mammalian Target of Rapamycin InhibitionCancer Research, 2009
- The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCLBlood, 2009
- Molecular basis of antifolate resistanceCancer and Metastasis Reviews, 2007
- Checking the Cox model with cumulative sums of martingale-based residualsBiometrika, 1993